Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Mar-24 5:12 PM View:  | Do Cuong V President & CEO Director | Biovie Inc. (BIVI) | 04-Mar-24 | Purchase | 10,000 | -- | -- | 2% 425.85K to 435.85K | |
| 13-Dec-23 5:15 PM View: | Kim Joanne Wendy Chief Financial Officer | Biovie Inc. (BIVI) | 11-Dec-23 | Grant | 5,000 | -- | -- | 13% 39.15K to 44.15K | |
| 06-Dec-23 4:16 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 01-Dec-23 | Sale | 75,680 | $1.69 | $127,899.00 | (62%) 122.04K to 46.36K | |
| 01-Dec-23 6:26 PM View: | Do Cuong V President & CEO Director | Biovie Inc. (BIVI) | 30-Nov-23 | Private Purchase | 10,000 | $1.78 | $17,800.00 | 2% 484.61K to 494.61K | |
| 06-Dec-23 4:15 PM View: | Berman Richard J Director | Biovie Inc. (BIVI) | 09-Nov-23 | Grant | 51,830 | -- | -- | 298% 17.41K to 69.23K | |
| 06-Dec-23 4:16 PM View: | Rogich Sigmund Director | Biovie Inc. (BIVI) | 09-Nov-23 | Grant | 42,254 | -- | -- | 100% 0 to 42.25K | |
| 06-Dec-23 4:16 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 09-Nov-23 | Grant | 46,358 | -- | -- | 61% 75.68K to 122.04K | |
| 06-Dec-23 4:15 PM View: | Hariri Robert J Director | Biovie Inc. (BIVI) | 09-Nov-23 | Grant | 42,254 | -- | -- | 100% 0 to 42.25K | |
| 07-Sep-23 6:20 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 05-Sep-23 | Sale | 8,560 | $3.05 | $26,108.00 | (10%) 84.24K to 75.68K | |
| 24-Aug-23 8:33 PM View: | Berman Richard J Director | Biovie Inc. (BIVI) | 22-Aug-23 | Sale | 10,805 | $3.50 | $37,827.20 | (39%) 27.59K to 16.79K | |
| 03-Jul-23 8:47 PM View: | Do Cuong V CEO & President Director | Biovie Inc. (BIVI) | 29-Jun-23 | Grant | 149,500 | -- | -- | 54% 276.35K to 425.85K | |
| 26-Jun-23 4:06 PM View: | Do Cuong V CEO & President Director | Biovie Inc. (BIVI) | 21-Jun-23 | Option Exercise | 41,506 | -- | -- | 18% 229.9K to 271.4K | |
| 15-Jun-23 5:15 PM View: | Berman Richard J Director | Biovie Inc. (BIVI) | 07-Jun-23 | Sale | 5,984 | $5.81 | $34,782.00 | (20%) 29.19K to 23.21K | |
| 15-Jun-23 5:15 PM View: | Berman Richard J Director | Biovie Inc. (BIVI) | 22-May-23 | Private Sale | 5,000 | $6.50 | $32,506.00 | (15%) 34.19K to 29.19K | |
| 06-Apr-23 9:02 PM View: | Berman Richard J Director | Biovie Inc. (BIVI) | 28-Mar-23 | Sale | 7,613 | $8.52 | $64,870.30 | (18%) 41.81K to 34.19K | |
| 06-Apr-23 9:02 PM View: | Berman Richard J Director | Biovie Inc. (BIVI) | 27-Mar-23 | Private Sale | 3,371 | $8.52 | $28,710.80 | (7%) 45.18K to 41.81K | |
| 22-Feb-23 5:48 PM View: | Ahlem Clarence N. EVP Neuroscience Product Dev. | Biovie Inc. (BIVI) | 16-Feb-23 | Payment of Exercise | 2,476 | $6.12 | $15,153.10 | (6%) 39.62K to 37.15K | |
| 22-Feb-23 7:31 PM View: | Palumbo Joseph M Chief Medical Officer | Biovie Inc. (BIVI) | 16-Feb-23 | Payment of Exercise | 2,476 | $6.12 | $15,153.10 | (6%) 39.62K to 37.15K | |
| 22-Feb-23 5:49 PM View: | Do Cuong V CEO & President Director | Biovie Inc. (BIVI) | 16-Feb-23 | Payment of Exercise | 4,953 | $6.12 | $30,312.40 | (2%) 234.85K to 229.9K | |
| 22-Feb-23 5:47 PM View: | Markham Penelope EVP Liver Cirrhosis R&D | Biovie Inc. (BIVI) | 16-Feb-23 | Payment of Exercise | 2,476 | $6.12 | $15,153.10 | (5%) 50.32K to 47.84K | |
| 22-Feb-23 5:49 PM View: | Kim Joanne Wendy Chief Financial Officer | Biovie Inc. (BIVI) | 16-Feb-23 | Payment of Exercise | 2,476 | $6.12 | $15,153.10 | (6%) 41.62K to 39.15K | |
| 22-Feb-23 5:47 PM View: | Reading Christopher EVP Neuroscience R&D | Biovie Inc. (BIVI) | 16-Feb-23 | Payment of Exercise | 2,476 | $6.12 | $15,153.10 | (6%) 39.62K to 37.15K | |
| 18-Jan-23 4:20 PM View: | Markham Penelope EVP Liver Cirrhosis R&D | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 39,624 | -- | -- | 371% 10.69K to 50.32K | |
| 18-Jan-23 4:22 PM View: | Berman Richard J Director | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 43,578 | -- | -- | 2724% 1.6K to 45.18K | |
| 18-Jan-23 4:21 PM View: | Kim Joanne Wendy Chief Financial Officer | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 39,624 | -- | -- | 1981% 2.0K to 41.62K | |
| 18-Jan-23 4:32 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 34,240 | -- | -- | 68% 50.0K to 84.24K | |
| 18-Jan-23 4:24 PM View: | Reading Christopher EVP Neuroscience R&D | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 39,624 | -- | -- | 100% 0 to 39.62K | |
| 18-Jan-23 4:24 PM View: | Hariri Robert J Director | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 34,240 | -- | -- | 100% 0 to 34.24K | |
| 18-Jan-23 4:22 PM View: | Ahlem Clarence N. EVP Neuroscience Product Dev. | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 39,624 | -- | -- | 100% 0 to 39.62K | |
| 18-Jan-23 4:25 PM View: | Lang James Paul Director | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 43,578 | -- | -- | 174% 25.04K to 68.62K | |
| 18-Jan-23 4:23 PM View: | Palumbo Joseph M Chief Medical Officer | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 39,624 | -- | -- | 100% 0 to 39.62K | |
| 18-Jan-23 4:20 PM View: | Do Cuong V CEO & President Director | Biovie Inc. (BIVI) | 23-Nov-22 | Grant | 79,248 | -- | -- | 51% 155.6K to 234.85K | |
| 16-Aug-22 5:11 PM View: | Peizer Terren S Director 10% Owner | Biovie Inc. (BIVI) | 15-Aug-22 | Grant | 3,636,360 | $1.65 | $6,000,000.00 | 19% 19.53M to 23.17M | |
| 16-Feb-22 5:24 PM View: | Adams Jonathan M EVP Liver Cirrhosis Programs | Biovie Inc. (BIVI) | 02-Feb-22 | Gift | 1,000 | -- | -- | (2%) 49.63K to 48.63K | |
| 25-Jan-22 12:31 PM View: | Do Cuong V President & CEO Director | Biovie Inc. (BIVI) | 31-Dec-21 | Grant | 21,710 | -- | -- | 16% 133.89K to 155.6K | |
| 09-Dec-21 4:46 PM View: | Kim Joanne Wendy CFO | Biovie Inc. (BIVI) | 07-Dec-21 | Market Purchase | 2,000 | $5.40 | $10,798.00 | 100% 0 to 2.0K | 2% |
| 29-Oct-21 5:09 PM View: | Adams Jonathan M EVP Liver Cirrhosis Programs | Biovie Inc. (BIVI) | 16-Jun-21 | Gift | 10,000 | -- | -- | (17%) 59.63K to 49.63K | |
| 26-Aug-22 5:10 PM View: | Peizer Terren S Director 10% Owner | Biovie Inc. (BIVI) | 10-Jun-21 | Grant | 8,361,310 | -- | -- | 54% 15.43M to 23.79M | |
| 15-Dec-20 3:01 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 03-Nov-20 | Purchase | 2,430 | $7.95 | $19,318.50 | 6% 42.67K to 45.1K | |
| 15-Dec-20 3:00 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 30-Oct-20 | Purchase | 2,570 | $7.97 | $20,482.90 | 6% 40.1K to 42.67K | |
| 22-Oct-20 3:10 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 21-Oct-20 | Purchase | 5,000 | $9.19 | $45,950.00 | 14% 35.1K to 40.1K | |
| 19-Oct-20 2:59 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 15-Oct-20 | Purchase | 10,000 | $10.06 | $100,550.00 | 28% 35.1K to 45.1K | |
| 19-Oct-20 2:59 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 15-Oct-20 | Purchase | 5,100 | $10.19 | $51,967.00 | 11% 45.1K to 50.2K | |
| 14-Oct-20 2:07 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 09-Oct-20 | Purchase | 282 | $9.61 | $2,710.02 | 1% 19.72K to 20.0K | |
| 14-Oct-20 2:05 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 07-Oct-20 | Purchase | 4,718 | $9.42 | $44,443.60 | 31% 15.0K to 19.72K | |
| 26-Aug-22 5:10 PM View: | Peizer Terren S Director 10% Owner | Biovie Inc. (BIVI) | 22-Sep-20 | Grant | 5,359,830 | -- | -- | 63% 8.52M to 13.88M | |
| 26-Aug-22 5:10 PM View: | Peizer Terren S Director 10% Owner | Biovie Inc. (BIVI) | 22-Sep-20 | Option Exercise | 1,549,750 | $0.00 | $154.98 | 11% 13.88M to 15.43M | |
| 14-Oct-20 1:49 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 22-Sep-20 | Purchase | 15,000 | $10.00 | $150,000.00 | 100% 0 to 15.0K | |
| 23-Oct-20 10:00 PM View: | Gorlin Steve Director | Biovie Inc. (BIVI) | 16-Jun-20 | Disposition (change in control) | -- | -- | -- | 0% -- | |
| 16-Nov-20 10:00 PM View: | Rogich Sigmund Director | Biovie Inc. (BIVI) | 16-Jun-20 | Disposition (change in control) | -- | -- | -- | 0% -- |
